GENETIC MARKERS AND OUTCOME WITH FRONT LINE OBINUTUZUMAB PLUS EITHER CHLORAMBUCIL OR VENETOCLAX ‐ UPDATED ANALYSIS OF THE CLL14 TRIALE Tausch,C Schneider,D Yosifov,S Robrecht,C Zhang,O Al‐Sawaf,B Eichhorst,A.‐M Fink,J Bloehdorn,K.‐A Kreuzer,M Tandon,Y Jiang,S. Y Kim,M Porro Lura,H Döhner,K Fischer,M Hallek,S StilgenbauerHematological Oncology（2021）引用 5|浏览9AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
